IXC 0.00% 7.0¢ invex therapeutics ltd

Ann: Postcard to Shareholders, page-28

  1. 8,477 Posts.
    lightbulb Created with Sketch. 1388
    What's the point of being bought out after a successful P3 when the drug is about to be approved anyway? By then you may as well market it youself, or licence it and keep overall control.

    An earlier buyout would be a different matter.

    Holding a decent parcel.
    Last edited by IndexInvestor: 19/03/21
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.000(0.00%)
Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 6.3¢ $5.263K 76.69K

Buyers (Bids)

No. Vol. Price($)
1 38879 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 13.14pm 20/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.